Renalytix Plc Share Price Börse Stuttgart
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.117 EUR | -16.43% | -26.70% | -17.16% |
25/06 | Shares in Renalytix plunge on possible ADS suspension on Nasdaq | AN |
25/06 | Renalytix to Appeal Nasdaq Delisting Over Non-compliance | MT |
Sales 2024 * | 2.5M 2.34M 209M | Sales 2025 * | 6.98M 6.51M 582M | Capitalization | 24.84M 23.2M 2.07B |
---|---|---|---|---|---|
Net income 2024 * | -32M -29.89M -2.67B | Net income 2025 * | -24M -22.42M -2B | EV / Sales 2024 * | 9.93 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.56 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 week | -26.70% | ||
Current month | -16.17% | ||
1 month | -33.33% | ||
3 months | -62.77% | ||
6 months | -4.76% | ||
Current year | -17.16% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15/18/15 |
Howard Doran
PSD | President | 63 | 01/23/01 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15/18/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30/21/30 |
Chairman | 72 | 15/18/15 | |
James McCullough
FOU | Founder | 56 | 15/18/15 |
Date | Price | Change |
---|---|---|
27/24/27 | 0.117 | -16.43% |
26/24/26 | 0.14 | -10.83% |
25/24/25 | 0.157 | -15.14% |
24/24/24 | 0.185 | -2.63% |
21/24/21 | 0.19 | 0.00% |
Delayed Quote Börse Stuttgart, June 27, 2024 at 07:58 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.99% | 14.88B | |
-54.36% | 2.26B | |
+16.54% | 1.89B | |
-11.85% | 1.52B | |
+19.90% | 1.19B | |
-29.99% | 871M | |
+2.21% | 781M | |
-35.68% | 750M | |
-29.02% | 591M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock